Peter Llewellyn-Davies is an experienced biotech executive with over 40 years of international
expertise in company formation, IPOs, M&A, and financing. As Founder & CEO of Accellerate
Partners, he supports management teams in scaling and implementing growth strategies. He is
Founder and President of BIOTECH AUSTRIA, serves as Chairman of ARTCLINE GmbH, Non-Executive Director of Shield
Therapeutics plc, and co-founded invIOs, a company developing innovative cancer
immunotherapies, including treatments for brain tumors (glioblastoma). Previously, he led the
restructuring and successful sale of Apeiron Biologics to a U.S. pharmaceutical group. Peter
has been recognized as a Fellow of the London Institute for Banking and Finance for his
contributions to global finance
CEO of the Year 2026
GLOBAL
Season
Rank
Move
Points
2026
#1032
-
<10
Title to be awarded:World CEO of the Year 2026
NATIONAL
Season
Rank
Move
Points
2026
#30
-
<10
Title to be awarded:Austria CEO of the Year 2026
REGIONAL
Season
Rank
Move
Points
2026
#4
-
<10
Title to be awarded:Oberösterreich CEO of the Year 2026
LOCAL
Season
Rank
Move
Points
2026
#1
-
<10
Title to be awarded:Altmünster CEO of the Year 2026
Performance Excellence Award 2026
Season
Rank
Points
2026
#1032
<10
Corporate Support Award 2026
Season
Rank
Points
2026
#1032
<10
Supporters
The list is still empty. Be the first to show your support!
Support Peter on Behalf of Your Company
Corporate support is free of charge. The number of votes awarded is based on your company's verified employee count.
To submit corporate support, you must hold a leadership position within the company and use an email address from your company's official domain.
